D-400-2014 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 15, 2014
- Initiation Date
- February 27, 2013
- Termination Date
- April 1, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Fenofibric Acid, immediate release tablet, 105 mg, a) 30 count bottle (NDC 53489-678-07), b) 90 count bottle (NDC 53489-678-90), Rx only, Mutual Pharmaceutical Co., Inc., Philadelphia, PA 19124 USA
Reason for Recall
Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice. Specifically, the labeling should read "If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated." The labeling for the recalled lots
Distribution Pattern
Nationwide and Puerto Rico.
Code Information
lot 6581105 & 6581106 exp. 07/15, and lot 6623001 & 6623002 exp. 01/16